Efficacy of digital therapeutic video games (Lumosity games) in treating ADHD A prospective comparative study

Technical Summary: Efficacy of Digital Therapeutic Video Games (Lumosity) in Treating ADHD

Problem Statement
Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity, significantly impacting academic, social, and functional domains. While current standard-of-care treatments involve a multimodal approach combining pharmacotherapy (stimulants and non-stimulants like Atomoxetine) and behavioral/parenting interventions, there is a growing interest in digital therapeutic video games as an adjunctive treatment. These games aim to target neural circuits responsible for attention and cognitive control through adaptive gameplay, potentially promoting neuroplasticity. However, evidence regarding the specific efficacy of commercial brain-training platforms like Lumosity as an add-on to standard care in adolescents remains limited, particularly in the Egyptian context.

Methodology
The study employed a prospective, comparative design conducted at the Child and Adolescent Psychiatry Clinic of ElHadra University Hospital, Alexandria, Egypt.

• Participants: 60 children and adolescents (aged 13–18) diagnosed with ADHD according to DSM-5-TR criteria were recruited. Inclusion criteria required an IQ >85 and the absence of comorbid psychiatric disorders, acute medical illness, or neurological conditions.
• Study Design: Participants were randomly divided into two groups (30 per group) using a simple randomization method (even/odd assignment).
  • Group A (Active Intervention): Received standard care (Atomoxetine 0.5–1.2 mg/kg + behavioral and parenting modification) plus 20-minute sessions of Lumosity digital therapeutic video games, three times weekly for 12 weeks.
  • Group B (Active Control): Received standard care (Atomoxetine + behavioral and parenting modification) only.
• Assessments: Data was collected at baseline and after 12 weeks using:
  • Conners' Continuous Performance Test 3rd Edition (CPT 3) for objective attention metrics.
  • Barkley Deficits in Executive Functioning Scale for Children and Adolescents (BDEFS-CA) for subjective executive function ratings.
  • Demographic and clinical interviews, including the General Health Questionnaire (GHQ-28) and Stanford-Binet IQ test.
• Statistical Analysis: Comparisons were made using paired t-tests for pre/post changes within groups and independent t-tests or Mann-Whitney U tests for between-group differences. Univariate linear regression was used to identify predictors of improvement.

Key Results

• Sample Attrition: The study experienced a dropout rate of 30% (18 participants total). Analysis revealed that dropouts were significantly associated with rural residency (p=0.017) and showed a trend toward lower informant education levels (p=0.053). The final analysis included 42 participants (20 in Group A, 22 in Group B).
• Baseline Equivalence: No significant differences were found between the two groups regarding demographics, IQ, ADHD severity, or baseline scores on CPT 3 and BDEFS-CA.
• CPT 3 Outcomes: Both groups demonstrated statistically significant improvements in most CPT parameters (Detectability, Omissions, Commissions, Hit Reaction Time) from pre- to post-treatment. Group A showed slightly higher mean improvement than Group B in most parameters, but the difference in the degree of improvement between the two groups was not statistically significant.
• BDEFS-CA Outcomes: Both groups showed significant improvement across all executive function parameters. However, Group A demonstrated a statistically significantly greater degree of improvement compared to Group B in two specific domains:
  • Self-management to time (p = 0.043)
  • Self-regulation of emotions (p = 0.012)
• Predictors of Improvement: Univariate linear regression analysis performed specifically on the active group (Group A) identified female sex as a significant predictor for improvement in both "self-management to time" and "self-regulation of emotions." No parameters were found to be predictors for improvement in the total sample.

Significance and Claims
The authors conclude that digital therapeutic video games (specifically Lumosity) represent a promising adjunctive treatment for ADHD when combined with pharmacotherapy and behavioral interventions. The study claims that while the addition of the game did not significantly outperform standard care in objective attention metrics (CPT 3), it did yield statistically significant additional benefits in specific executive function domains, particularly time management and emotional regulation.

The paper modestly notes that the lack of statistical significance in most CPT parameters may be due to the high efficacy of the standard multimodal treatment (medication + behavioral therapy) already achieved by the control group, potentially creating a ceiling effect. The authors emphasize that the observed improvements in executive functions suggest that digital games can effectively target functional daily living skills. Furthermore, the finding that female adolescents in the active group showed greater responsiveness to the digital intervention highlights a potential demographic variable for future personalized treatment strategies.

Limitations
The authors acknowledge several limitations, including the small sample size, the absence of a group receiving the game without medication (which limits the isolation of the game's specific effect), the lack of an Arabic-language version of the game (relying on English), and the short duration of the study (12 weeks) without long-term follow-up. Additionally, the high dropout rate among rural participants suggests accessibility barriers for digital interventions in non-urban settings.